By Alptamise Hailey-Hinds
Advanced BioNutrition Corp. (ABN), a leader in providing science-based solutions to improve health and nutrition, announced the signing of a third agreement with its South American strategic partner, Centrovet Laboratories, in Santiago, Chile.
Centrovet employs about 268 people, 62 of them, are professionals from different backgrounds, including; Pharmacists, Chemists, Biologists, Biochemists, Microbiologists, Veterinarians and Engineers. It’s important to point out that among these professionals 4 holds PhDs, and 7 Master in Science degrees. Centrovet’s bio-engineers and other scientists are developing new solutions and prevention methods for our current global animal health issues.
Centrovent, the creators of a line of injectable and oral vaccines for use against major diseases present a new bi-valent ISA+SRS oral vaccine. This unique bi-valent ISA+SRS oral vaccine is delivered via commercial feed using ABN’s patented delivery systems.
With ABN’s delivery system a more efficient version of the active ingredients, that act to stabilize, protect, and direct the product to its final target site of action. In addition the system can be used for the delivery of probiotics, omega-3 oils, vitamins, carotenoids, enzymes, and amino acids for human nutrition and industrial applications.
Farmers who vaccinate by injection may now see better results in the health of their animals with a new polyvalent oral vaccine strategy, more accurately preventing ISA and SRS. “It is expected that the use of the vaccine, in conjunction with proper disease management, will significantly reduce the losses due to this ISAV pathogen,” said David Farcas, CEO, Centrovet.
The ISA (Infectious Salmon Anemia virus) was first found in Atlantic salmon being farmed along the coast of Norway. SRS (Salmon Rickettsial Syndrome) was first reported, in Chile in 1989. The bacteria, Pisci-rickettsia salmons, now frequently associated with disease syndromes in both salmon and non-salmon fish from both fresh and saltwater worldwide was considered to be the cause of death of an estimated 1.5 million Coho salmon.
All of ABN’s technologies employ patented and patent-pending embedding processes using materials acceptable for customers’ stewardship and regulatory needs.
ABN director of business development for animal health, George R. Kohan, said “This is not an evolutionary step but a revolutionary step in the management of animal diseases,” “There has never been a freeze-dried, powdered, oral bi-valent vaccine for fish health management and it may well be that this is the first of its type for management of any animal disease. This allows farmers to replace injection with a vaccine top-coat on the regular feed. We are pleased to be a part of this accomplishment by the Centrovet research team.”
In 1972, PCB production plants existed in Austria, the then Federal Republic of Germany, France, Great Britain, Italy, Japan, Spain, USSR, and USA.
In 1973, the use of PCBs was banned in sources, such as: plasticizers in paints and cements, casting agents, fire retardant fabric treatments and heat stabilizing additives for PVC electrical insulation, adhesives and paints and water-proofing.